Blood Transfusion Reaction in neonates & management

Slides:



Advertisements
Similar presentations
Administration of Blood and Blood Products PN 3 November 2005.
Advertisements

Transfusion A blood transfusion is a safe, common procedure in which you receive blood through an intravenous (IV) line inserted into one of your blood.
Transfusion ComplicationRisk per UNIT Allergic3:100 Febrile (Leuko-reduced Units) 1:100 TACO1:100 TRALI1:5,000 Sepsis1:5,000 Acute hemolytic1:75,000 HBV1:160,000.
Adverse Effects of Blood Transfusion. Adverse Effects of Blood Transfusion ANY unfavorable consequence is considered an adverse effect of blood transfusion.
Components of Blood Formed elements-Cells – Erythrocytes (RBCs) – Leukocytes (WBCs) – Thrombocytes (platelets) Plasma – 90% water – 10% solutes – Proteins,
Transfusion Medicine Eiad Kahwash,MD,FASCP
INDICATIONS FOR EMERGENT TRANSFUSIONS Manjushree Matadial DO Saint Joseph Hospital and Medical Center, April 27,2009.
4th year medical students 2nd Feb,2008 Transfusion Medicine III Complications and Safety of Transfusion Practices Salwa Hindawi Medical Director of Blood.
1 Massive Blood Transfusion Massive transfusion, defined as the replacement by transfusion of more than 50 percent of a patient's blood volume in 12 to.
BLOOD PHYSIOLOGY Practical 1
Welcome.
Adverse Effects of Blood Transfusion. Adverse Effects of Blood Transfusion ANY unfavorable consequence is considered an adverse effect of blood transfusion.
Adverse Reactions to Blood Transfusion. Learning objectives  To Identify the different types of transfusion reactions  To investigate and report of.
BLOOD TRANSFUSION Begashaw M (MD).
Adult Health Nursing II Block 7.0. Blood Products and Blood Transfusions Adult Health II Block 7.0 University of Southern Nevada Block 7.0 Module 1.3.
Transfusion of Blood Product History: 1920:Sodium citrate anticoagulant(10 days storage) 1958: Plastic bag of transfusion 1656: Initial theory and.
Risks and Indications for RBCs Transfusions David Stroncek, MD Chief, Laboratory Services Section Department of Transfusion Medicine, Clinical Center,
BLOOD TRANSFUSION BRI BUDLOVSKY R3 JANUARY OVERVIEW The process Blood components Testing Consent Transfusion reactions.
Transfusion Emergencies. TRANSFUSION REACTIONS IMMUNOLOGIC NON-IMMUNOLOGIC.
Transfusion Reactions June Objectives  Be able to recognize the more common transfusion reactions  Learn about treatment and prevention of transfusion.
BLOOD TRANSFUSION AND TRANSFUSION REACTIONS
上海交通大学瑞金临床医学院 外科教研室. Blood Transfusion History Type of Transfusion Indication Transfusion Reactions Autologous transfusion Component Transfusion Blood.
Transfusion Therapy Principles of IV Therapy BSN336.
Blood Component Therapy
Acute Transfusion Reactions Clinical Symptoms and Laboratory Investigation.
FEBRILE NONHEMOLYTIC TRANSFUSION REACTIONS
RESULTS FROM THE 2007 SHOT REPORT. SHOT report 2007 (561 cases)
The Ubiquitous HLA System: applications in transfusion and transplantation Dr Mary Purna Chacko Department of Transfusion Medicine and Immunohaematology.
BLOOD ADMINISTRATION NRS 108 ESSEC COUNTY COLLEGE Majuvy L. Sulse MSN, RN,CCRN.
Transfusion Reactions
RESULTS FROM THE 2006 SHOT REPORT. SHOT report 2006.
Faculty of Allied Medical Science Blood Banking (MLBB 201)
Transfusion Reactions Lloyd O. Cook, M.D. Department of Pathology March 2005.
Lecture 7 blood bank BLOOD TRANSFUSION REACTION Non immunological Dr. Dalia Galal.
Transfusion Medicine Kristine Krafts, M.D.. Blood groups Introduction ABO system Rh system Other systems Blood transfusion Blood products Indications.
The complications can be broadly classified into two categories: Immune Complications Non-immune Complications.
M.Senn, Swissmedlab Okt Hemovigilance in Switzerland Marianne Senn, ART (CSMLS) Head of Hemovigilance Swissmedic / Swiss Agency for Therapeutic Products.
BLOOD TRANSFUSION Ferdi Menda,M.D. Associated Prof of Anesthesiology Yeditepe University.
Blood and Blood Products. Whole Blood n Contents –RBC’s –WBC’s –Platelets –Plasma –Clotting factors.
CARE OF THE PATIENT RECEIVING BLOOD/BLOOD COMPONENTS.
MANAGEMENT OF ACUTE TRANSFUSION REACTIONS
Immunology of blood transfusion
Blood Transfusions.
BLOOD TRANSFUSION Blood transfusion is generally the process of receiving blood or blood products into one's circulation intravenously. Transfusions are.
Blood transfusion complications Infectious & non infectious
Transfusion practice in anesthesia
Transfusion Medicine Kristine Krafts, M.D..
TRANSFUSION REACTIONS
BLOOD & BLOOD PRODUCTS.
Transfusion Medicine: Types, Indications and Complications
د.محمد حارث الساعاتي.
2015 Haemovigilance Report Tables and Figures
TRANSFUSION RELATED ACUTE LUNG INJURY(TRALI)
Intravenous Fluid Administration
Indication of Blood Transfusion in Newborns Dr Bijan Keikhaei Full Professor of Pediatric Hematology and Oncology Research Center for Thalassemia and.
BLOOD TRANSFUSION An overview
NUR 422 Blood administration
BLOOD TRANSFUSION Ferdi Menda,M.D. Assistant Prof of Anesthesiology
Transfusion Medicine Kristine Krafts, M.D..
Immunohematology (Introduction)
Blood Typing A, B, AB and O Blood Types.
Part 3.
Blood and Blood Product Transfusion Reaction
Blood Transfusion Review 2/3/2018
Non-Antibody Mediated TRALI
Recent advances – TRALI
Transfusion Medicine Kristine Krafts, M.D..
Complications of Transfusion
Complications of Blood Transfusion
Dr. Kareema Ahmed Hussein
Presentation transcript:

Blood Transfusion Reaction in neonates & management Dr. Azita Azarkeivan Pediatric Hematology Oncology Adult Thalassemia Clinic

Complications of Transfusion Transfusion reactions occur in 2% of units or within 24 hours of use. Most common adverse side effects are usually mild and non-life-threatening In New born and infants these complications may have some differences

Complications of Transfusion in newborn and infants Small Blood volume Passive transfer of maternal antibody Immature Immune system CMV , TA-GVHD

Transfusion Side effects Acute Hemolytic Reaction Delayed Hemolytic Reaction Febrile Non hemolytic Reaction Allergic Reaction Iron Over Load TX Related Acute Leukocyte Lung Injury Transfusion Transmitted Infections Volume Over Load, Electrolyte Imbalance

Complications of Transfusions Two Categories Acute (< 24 hr ) Immunologic Non-immunologic Delayed (> 24 hr)

Acute Immunologic (< 24 hr) Transfusion Reactions

Acute (< 24 hr) Immunologic Hemolytic Febrile ; Fever , chills, non-hemolytic Allergic ; Urticarial , non-hemolytic Transfusion-related acute lung injury (TRALI) Anaphylactic ( IgA related)

Acute (< 24 hr) Immunologic Hemolytic Mostly ABO incompatibility A clerical error (wrong specimen, wrong patient) Sever hemolysis , In new born the ABO gp antigens not developed well and also their antibodies are not in high level But The maternal antibodies may pass from mother and these antibodies may produce hemolysis in new born Prevention : Correct ABO grouping of patient and blood bag Careful cross match with maternal serum

Acute (< 24 hr) Immunologic Febrile FNHTR , Rise in temperature by 2F or 1C HLA alloab of pt against Donor’WBC Recipient has WBC antibodies against donor WBCs contained within RBCs and Platelet products No hemolysis, Often occurs after multiple blood transfusions. In newborn and infants not very common Prevention : Use of leukoreduced product It should be to rolled out the other causes for fever for the patient Anti pyretic should use if there is no other cause

Acute (< 24 hr) Immunologic Allergic Allergic reaction to Donor’s plasma proteins Urticaria, itching, flushing, wheezing No hemolysis, Often occurs after multiple blood transfusions. In newborn and infants not very common Prevention : Use of Antihistamin

Acute (< 24 hr) Immunologic Transfusion-related acute lung injury (TRALI) Transfusion related pulmonary edema Donor plasma contains WBC antibodies that when transfused to the recipient cause agglutination of recipient’s WBC in the pulmonary capillary beds Chest X ray looks like ARDS Signs/Symptoms: Circulatory overload (TACO), Allergic/Anaphylactic Bacterial ;Acute hemolytic reaction Clinical presentation (“classic”, severe form) Acute respiratory distress,Pulmonary edema Hypoxemia,,Hypotension Rx usually within 6 hr (majority of cases during tx or within 2 hr of tx

Acute (< 24 hr) Immunologic Transfusion-related acute lung injury (TRALI) Insidious, acute onset of pulmonary insufficiency Profound hypoxemia ; PaO2/FiO2 < 300 mmHg CXR ; fluffy infiltrates , pulmonary edema Cardiac ; PA wedge pressure  18 mmHg Treatment/Prevention Discontinue transfusion Supportive care Epinephrine Antihistamine/steroids In IgA deficient pts.  IgA-deficient product, wash blood product

Acute Non Immunologic (< 24 hr) Transfusion Reactions

Acute (< 24 hr) Non-Immunologic Circulatory overload Air embolus Hypocalcemia Hypothermia Hyperkalemia

Acute (< 24 hr) Non-Immunologic Circulatory overload Acute pulmonary edema due to volume overload One of the most common complications of transfusion Common in newborn and infants Cardiac and pulmonary compromise Dyspnea, cyanosis, CHF during or soon after transfusion Prevention ; slow rate of transfusion , Care full estimation of volume of transfusion , Treatment ; stop Tx , Use of diuretics

Acute (< 24 hr) Non-Immunologic Air Embolism Air infusion via line of product transfusion Cough, dyspnea, chest pain, shock Prevention ; Care full transfusion via the trained and well experienced Nurse Treatment ; stop Tx , Pt. placed on left side with head down , Displace air bubble from pulmonary valve

Acute (< 24 hr) Non-Immunologic Metabolic Complications ; Hypocalcemia If Large volumes of product transfused rapidly ; plasma citrate levels may rise ; binds iCa+2 Citrate rapidly metabolized ; manifestations transient peripheral tingling , paresthesias,, tetanic seizure, hyperventilation, depressed cardiac function Prevention ; Control the calcium level Treatment ; Ca+2 replacement

Acute (< 24 hr) Non-Immunologic Metabolic Complications ; Hyperkalemia If old ( more than 2 weeks ) product transfused ; RBC Lysis may increase potassium level ; Irradiation product may increase the rate of leak Cardiac arrhythmia, electrolyte imbalance Prevention ; Control the potassium level Treatment ; potassium replacement

Acute (< 24 hr) Non-Immunologic Metabolic Complications ; Hypothermia Rapid infusion of large volumes of cold blood Ventricular arrhythmias More likely via central catheters Increased toxicity of hypocalcemia and hyperkalemia Impaired hemostasis , Increase caloric requirement May be common in newborn and infants Prevention ; slow rate of transfusion , Blood warmer Treatment ; warm the patient

Delayed Immunologic (> 24 hr) Transfusion Reactions

Delayed (> 24 hr) Immunologic Alloimmunization RBC antigens HLA Leukocyte Antigens Graft-versus-host disease (GVHD) Post-transfusion purpura Immuno modulation

Delayed (> 24 hr) Immunologic Allo-immunization Occurs weeks to months after transfusion Incidence ; 1-1.6% to RBC antigens ; 10% to HLA In new born and infants not very common Signs/Symptoms: PRBCs ; hemolysis Plts. ; refractoriness Treatment/Prevention :Leukoreduction ,Cross-matched and/or HLA-matched plts.

Delayed (> 24 hr) Immunologic Graft-versus-host disease (GVHD) Fatal complication cause by clonal expansion of donor T lymphocytes in immunocompromized host New borns and infants have immature immune system are susceptible to this event Signs/Symptoms;Appears in 10-12 days of transfusion Skin ; whole body erythroderma, desquamation GI ; diarrhea Liver; high liver enayme BM ; failure leading to pancytopenia Treatment/Prevention; Gamma irradiation T-cells inactivation by irradiation of2500 cGy to the product for 4.5 min

Delayed Non Immunologic (> 24 hr) Transfusion Reactions

Delayed (> 24 hr) Non-Immunologic Iron overload ( in repeated Tx ) Transfusion Transmitted Infections (TTI)

Delayed (> 24 hr) Non-Immunologic Transfusion Transmitted Infections (TTI) HBV 1 in 63,000 HCV 1 in 103,000 HTLV-I 1 in 641,000 HTLV-II 1 in 641,000 HIV-1 1 in 587,000 HIV-2 < 1 in 1,000,000 Since 1999 the risks of infection have been greatly reduced by new laboratory tests (NAT or nucleic acid testing or PCR )

Transfusion Transmitted Infections (TTI) Cytomegalovirus (CMV) is important in newborn and infants specially in the CMV seronegative pregnant woman/fetus or premature infants (<1200g) of CMV seronegative mothers.(CMV “safe” blood) For Full term or premature infants of CMV seropositive mothers: ? pre-storage leukoreduced cellular components

Conclusion of Tx Rx in new born and infants Small Blood volume Passive transfer of maternal antibody Immature Immune system CMV , TA-GVHD Risk of metabolic Complication Ca,K , Glucose , Hypothermia Cross match with maternal Serum Use of repeated donors CMV neg products , Irradiated product

Thank You